AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $554.0M, listed on NASDAQ, employing roughly 57 people, carrying a beta of 0.00 to the broader market. AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. Led by Tim Knotnerus, public since 2024-05-29.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for AGMB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →